The Economic Times

Zydus Lifesciences in focus after USFDA clears Ahmedabad plant, Aflibercept biosimilar launch

Zydus Lifesciences is in focus after receiving USFDA clearance with zero observations for its Ahmedabad facility and launching ANYRA, Indias first indigenous Aflibercept biosimilar. The developments strengthen its regulatory standing and expand its ophthalmology portfolio, positioning the company to tap into a large and growing domestic market for retinal therapies.